Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Change in Cash (2023)

Historic Change in Cash for ADC Therapeutics (ADCT) over the last 5 years, with Q4 2023 value amounting to -$32.0 million.

  • ADC Therapeutics' Change in Cash rose 7713.97% to -$32.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$48.0 million, marking a year-over-year increase of 6566.93%. This contributed to the annual value of -$27.6 million for FY2024, which is 4243.24% up from last year.
  • ADC Therapeutics' Change in Cash amounted to -$32.0 million in Q4 2023, which was up 7713.97% from -$37.0 million recorded in Q3 2023.
  • In the past 5 years, ADC Therapeutics' Change in Cash registered a high of $36.9 million during Q2 2023, and its lowest value of -$139.8 million during Q4 2022.
  • For the 5-year period, ADC Therapeutics' Change in Cash averaged around -$14.7 million, with its median value being -$53951.0 (2022).
  • Over the last 5 years, ADC Therapeutics' Change in Cash had its largest YoY gain of 6849910.29% in 2023, and its largest YoY loss of 85901778.91% in 2023.
  • Quarter analysis of 5 years shows ADC Therapeutics' Change in Cash stood at -$34078.0 in 2019, then tumbled by 96372.8% to -$32.9 million in 2020, then surged by 99.81% to -$63679.0 in 2021, then plummeted by 219453.96% to -$139.8 million in 2022, then skyrocketed by 77.14% to -$32.0 million in 2023.
  • Its last three reported values are -$32.0 million in Q4 2023, -$37.0 million for Q3 2023, and $36.9 million during Q2 2023.